Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA?Wenhua Wu, Hai Lin, Jingwen Cai, Hong Sun,Jia Jenny Liu, Cheng Hu, Xingzhong WeiClinical Drug Investigation（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
